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tions, including contralateral carotid artery occlusion (20%), heart
disease (41%), and hypertension (72%), among other illnesses.
In conclusion, currently CEA is considered the standard for
treating severe (70%) carotid stenosis. CAS should be regarded as
a valid option only if it provides results equal to or better than those
of CEA. No doubt CAS has some advantages; it is a less invasive
and less time-consuming procedure, and is associated with a lower
incidence of cranial nerve injury. However, CEA performed after
noninvasive diagnostic testing and with the patient under local
anesthesia can provide better results in the subgroup of patients
with comorbid conditions.
Presently, CAS should be preferred for treatment of recurrent
stenosis caused by myointimal hyperplasia, post-irradiation, and
long or distal stenoses. In the future CAS may replace CEA in all,
or almost all, patients if technical progress and experience increase
the safety and results of the procedure.
Germano Lucertini, MD
Sezione di Chirurgia Vascolare
Universita` degli Studi di Genova
Genoa, Italy
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Reply
My coauthors and I appreciate the comments from Dr Lucer-
tini. I suspect that we are in near-agreement on clinical indications
for carotid endarterectomy (CEA) and stenting (CAS). His results
with CEA in a clinical series with good and high-risk patients are
superb. While our current indications for CAS include restenosis
after CEA, radiation-induced stenoses, and anatomically high le-
sions, the group with medical comorbidities constitutes a more
controversial category. We have defined the category in our pub-
lication and recommend CAS in this subset of patients. Although
CEA and CAS appear to have comparable 30-day stroke and death
rates in a recent randomized comparison,1 surgeons with results
similar to those of Dr. Lucertini in the high-risk group should
continue to select CEA on the basis of local practice and referral
patterns. For good-risk patients, CEA continues to be the pre-
ferred procedure pending results from ongoing randomized clini-
cal trials such as CREST2 or other national and international
efforts.
Robert W. Hobson II, MD
New Jersey Medical School
Newark, NJ
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Regarding “Graft patency is not the only clinical
predictor of success after exclusion and bypass of
popliteal artery aneurysms”
Jones et al (J Vasc Surg 2003;37:392-8) investigated three
types of popliteal aneurysm exclusion: proximal and distal ligation
with short (type I) and long (type II) segment isolation, and single
proximal or distal ligation (type III). On the basis of ultrasound
scans used to determine size, patency, and feeding branches in 36
limbs, the authors found that exclusion required adequate vascular
isolation of the aneurysm to prevent late enlargement. Inasmuch as
type I exclusion was found superior to both type II and type III
exclusion with regard to aneurysm diameter reduction over time,
the authors concluded that exclusion is best performed with prox-
imal and distal ligation directly adjacent to the aneurysm.
However, independent of the type of exclusion, aneurysms
with visualized feeding branches were associated with a significant
degree of late enlargement. This finding is of major importance,
because patent branches cannot be treated with an exclusion
technique when ligation of the popliteal artery alone is performed.
Jones and colleagues did not mention the dorsal approach to
the popliteal artery, through the popliteal fossa. However, this
method may be advantageous in treatment of popliteal aneurysm
in at least half of patients.1 Provided distinct criteria are met, such
as absence of aneurysm involvement of the femoral artery or the
common peroneal trunk, this approach facilitates reduced morbid-
ity. The procedure is carried out with the patient in a prone
position. Exposure of the aneurysm in the popliteal fossa is excel-
lent, and it is incised longitudinally, similar to the technique in
aortic aneurysm surgery. After debridement or excision, which
eliminates pressure symptoms and the possibility of late rupture, all
tributary vessels can be tied or clipped under direct visualization
and a reversed vein graft, or occasionally an expandable polytetra-
fluoroethylene interposition graft, is placed in the aneurysm sack.2
As a result of better hemodynamic performance of the end-to-end
anastomoses (restoring the anatomic course), the rate of postop-
erative thromboembolic complications is significantly reduced,
resulting in better long-term graft patency.3
We agree with Jones and colleagues that graft patency is not
the only clinical predictor of success after exclusion and bypass of
popliteal artery aneurysms. However, with regard to symptoms
and late rupture, the posterior approach must be mentioned as a
valuable, and in our view superior, alternative.
Omke E. Teebken, MD
Maximilian A. Pichlmaier, MA, MD
Axel Haverich, MD, PhD
Division of Thoracic and Cardiovascular Surgery
Hannover Medical School
Hannover, Germany
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